Development and validation of a high throughput screening platform to enable target identification in skeletal muscle cells from Duchenne Muscular Dystrophy (DMD) patients
S. Hariharan, O. Lorintiu, C. W. Lee, E. Duchemin-Pelletier, X. Li, A. Healy, R. Doyonnas, L. Selig, P. Poydenot, E. Ventre, A. Weston, J. Owens, N. Christoforou
The paper develops and validates a high throughput screening platform using morphological profiling to predict DMD disease phenotype in patient-derived myotubes.
bioRxiv · May 24, 2023 · PreprintCell Biology